Pfizer announced Wednesday, Nov.
18 that final trial analysis found its vaccine to be 95% effective with no major safety concerns.
Moderna seeks U.S., EU vaccine authorization
Reuters - Politics
[NFA] Moderna will apply for U.S. and European emergency-use authorization for its COVID-19 vaccine on Monday after full results..
